Trial · NCT07901101
Registered outcomes12
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 12 of 12
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Mean Acceptability Score on the RAPID Response Acceptability Questionnaire | Day 0 (before emergency department discharge) | Mean of 14 items based on the Theoretical Framework of Acceptability (TFA), each rated 1 (strongly disagree) to 5 (strongly agree). Possible range 1-5; higher scores mean greater acceptability of starting PrEP in the emergency department. |
| Secondary | Mean Acceptability Score at Follow-up | 48-72 hours, 30 days, 60 days, 90 days and 365 days after discharge | Same 14-item TFA-based score (range 1-5; higher = greater acceptability), reported separately at each timepoint. |
| Secondary | Percentage of Approached Patients Who Enroll | Throughout enrollment, up to 6 months | Number of patients who consent divided by the number of patients aged 18 or older approached by the peer navigator, as a percentage. |
| Secondary | Number of Participants Who Take the First PrEP Dose | Up to 72 hours after discharge | Count of enrolled participants whose first dose is observed in the emergency department or, by exception, by video or in person within 72 hours |
| Secondary | Percentage of Participants Linked to PrEP Care at 30 Days | 30 days after discharge | Percentage of participants who attend a visit with a community PrEP provider within 30 days of discharge, confirmed by the navigator. |
| Secondary | Percentage of Participants Linked to PrEP Care at 90 Days | 90 days after discharge | Percentage of participants with a confirmed visit with an ongoing PrEP provider by 90 days. |
| Secondary | Percentage of Participants Still Taking PrEP | 90 days and 365 days after discharge | Percentage of participants who report taking PrEP at the time of contact. |
| Secondary | Percentage of Participants With Follow-up PrEP Laboratory Testing | 120 days after discharge | Percentage of participants whose outside PrEP provider confirms follow-up PrEP labs and a PrEP prescription. |
| Secondary | Change in PrEP Knowledge Score | Day 0, before and after education | Number correct on a 9-item true/false PrEP knowledge check (range 0-9; higher = more knowledge), after education minus before education. |
| Secondary | Number of Participants With a New HIV Diagnosis After Starting PrEP | Up to 365 days after discharge | Count of participants with a positive HIV result after the first dose, including a positive confirmatory HIV-1 RNA test after discharge. |
| Secondary | Number of Participants Who Stop PrEP Because of Side Effects | Up to 365 days after discharge | Count of participants who report stopping PrEP because of side effects. |
| Secondary | Time From Navigator Contact to First PrEP Dose | Day 0 | Median minutes from the navigator's first bedside contact to the observed first dose. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT07901101/registered